The new apolipoprotein A-I variant Leu174 → Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93- residue N-terminal polypeptide

American Journal of Pathology

Volumn 155, Issue 3, 1999, Pages 695-702

  Obici, Laura ^a,b   Bellotti, Vittorio ^a,b   Mangione, Palma ^a,b   Stoppini, Monica ^b   Arbustini, Eloisa ^a   Verga, Laura ^a   Zorzoli, Irene ^b   Anesi, Emesto ^b   Zanotti, Giuseppe ^c   Campana, Carlo ^a   Vigano, Mario ^b   Merlini, Giampaolo ^a,b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEUCINE; PROTEIN SUBUNIT; SERINE PROTEINASE; TRIACYLGLYCEROL;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; HEART AMYLOIDOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MISSENSE MUTATION; MUSCLE FIBRIL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 0032887169     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65167-X     Document Type: Article

References (23)

1. Genschel J, Haas R, Propsting MJ, Schmidt HHJ: Apolipoprotein A-I induced amyloidosis. FEBS Lett 1998, 430:145-149
2. Westermark P, Mucchiano G, Marthin T, Johnson KH, Sletten K: Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am J Pathol 1995, 147:1186-1192
3. Johnson KH, Sletten K, Hayden DW, O'Brien TD, Roertgen KE, Westermark P: Pulmonary vascular amyloidosis in aged dogs: a new form of spontaneously occurring amyloidosis derived from apolipoprotein AI, Am J Pathol 1992, 141:1013-1019
4. Amarzguioui M, Mucchiano G, Haggqvist b, Westermark P, Kavlie A, Sletten K, Prydz H: Extensive intimai apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation. Biochem Biophys Res Commun 1998, 242:534-539
5. Glomset JA: The plasma lecithins: cholesterol acyltransferase reaction. J Lipid Res 1968, 9:155-167
6. Ishida BY, Frolich J, Fielding CJJ: Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer. Lipid Res 1987, 28:778-786
7. Nichols WC, Gregg RE, Brewer HB, Benson MD: A mutation in apolipoprotein AI in the Iowa type of familial amyloidotic polyneuropathy. Genomics 1990, 8:318-323
8. Vigushin DM, Gough J, Allan D, Alguacil A, Penner B, Pettigrew NM, Quinonez G, Bernstein K, Booth SE, Booth DR, Soutar AK, Hawkins PN, Pepys MB: Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg 26. Q J Med 1994, 87:149-154
9. Booth DR, Tan SY, Booth SE, Hsuan JJ, Totty NF, Nguyen O, Hutton T, Vigushin DM, Tennent GA, Hutchinson WL, Thomson N, Soutar AK, Hawkins PN, Pepys MB: A new apolipoprotein AI variant, Trp50Arg, causes hereditary amyloidosis. Q J Med 1995, 88:695-702
10. Soutar AK, Hawkins PN, Vigushin DM, Tennent GA, Booth SE, Hutton T, Nguyen O, Totty NF, Feest TG, Hsuan JJ, Pepys MB: Apolipoprotein AI mutation Arg 60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci USA 1992, 89:7389-7393
11. Persey MR, Booth DR, Booth SE, Van Zyl Smit R, Adam BK, Fattaar AB, Tennent GA, Hawkins PN, Pepys MB: Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein AI. Kidney Int 1998, 53:276-281
12. Booth DR, Tan SY, Booth SE, Tennent GA, Hutchinson WL, Hsuan JJ, Totty NF, Truong O, Soutar AK, Hawkins PN, Bruguera M, Caballeria J, Sole M, Campistol JM, Pepys MB: Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene. J Clin Invest 1996, 97:2714-2721
13. Asl LH, Liepnieks JJ, Asl KH, Uemichi T, Moulin G, Desjoyaux E, Loire R, Delpech M, Grateau G, Benson MD: Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol 1999, 154:221-227
14. Walsh MT: A novel amyloidogenic variant of apolipoprotein AI. Implications for a conformational change leading to cardiomyopathy. Am J Pathol 1999, 1:11-14
15. Aprile C, Marinone G, Saponaro R, Bonino C, Merlini G: Cardiac and pleuropulmonary AL amyloid imaging with technetium-99 m labelled aprotinin. Eur J Nucl Med 1995, 22:1393-1401
16. Coates PJ, D'Ardenne AJ, Khan G, Kangro HO, Slavin G: Simplified procedure for applying the polymerase chain reaction to routinely fixed paraffin wax. J Clin Pathol 1991, 44:115-118
17. Arbustini E, Morbini P, Verga L, Concardi M, Porcu E, Pilotto A, Zorzoli I, Garini P, Anesi E, Merlini G: Light and electron microscopy immunohistochemical characterization of amyloid deposits. Amyloid 1997, 4:157-170
18. Shoulders CC, Kornblihtt AR, Munro BS, Baralle FE: Gene structure of human apolipoprotein A1. Nucleic Acids Res 1983, 9:2827-2837
19. Rader DJ, Gregg RE, Meng MS, Schaefer JR, Zech LA, Benson MD, Brewer HB Jr: In vivo metabolism of a mutant apolipoprotein, apoA-I Iowa, associated with hypoalphalipoproteinemia, and hereditary systemic amyloidosis. J Lipid Res 1992, 33:755-763
20. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 1995, 36:211-228
21. Borhani DW, Rogers DP, Engler JA, Brouillette CG: Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc Natl Acad Sci USA 1997, 94:12291-12296
22. Marcel YL, Provost PR, Koa H, Raffai E, Dac NV, Fruchart JC, Rassart E: The epitopes of apolipoprotein A-I define distinct structural domains including a mobile middle region. J Biol Chem 1991, 266: 3644-3653
23. Bergeron J, Frank PG, Scales D, Meng QH, Castro G, Marcel YL: Apolipoprotein A-I conformation in reconstituted discoidal lipoproteins varying in phospholipid and cholesterol content. J Biol Chem 1995, 27:27429-27438